Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Short-Term Debt repayments (2017 - 2025)

Historic Short-Term Debt repayments for Xtant Medical Holdings (XTNT) over the last 6 years, with Q3 2025 value amounting to $26.5 million.

  • Xtant Medical Holdings' Short-Term Debt repayments rose 270.94% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.5 million, marking a year-over-year increase of 515.94%. This contributed to the annual value of $105.1 million for FY2024, which is 3659.06% up from last year.
  • Xtant Medical Holdings' Short-Term Debt repayments amounted to $26.5 million in Q3 2025, which was up 270.94% from $25.9 million recorded in Q2 2025.
  • Xtant Medical Holdings' Short-Term Debt repayments' 5-year high stood at $27.5 million during Q2 2024, with a 5-year trough of $12.3 million in Q1 2022.
  • Its 5-year average for Short-Term Debt repayments is $20.1 million, with a median of $20.1 million in 2023.
  • Per our database at Business Quant, Xtant Medical Holdings' Short-Term Debt repayments crashed by 635.52% in 2022 and then skyrocketed by 5503.61% in 2024.
  • Over the past 5 years, Xtant Medical Holdings' Short-Term Debt repayments (Quarter) stood at $13.5 million in 2021, then grew by 10.6% to $14.9 million in 2022, then soared by 49.44% to $22.3 million in 2023, then grew by 21.75% to $27.1 million in 2024, then fell by 2.33% to $26.5 million in 2025.
  • Its Short-Term Debt repayments was $26.5 million in Q3 2025, compared to $25.9 million in Q2 2025 and $26.0 million in Q1 2025.